The development and characterization of SDF1α-elastin-like-peptide nanoparticles for wound healing

Journal of Controlled Release

Volumn 232, Issue , 2016, Pages 238-247

  Yeboah, Agnes ^a   Cohen, Rick I ^b   Faulknor, Renea ^b   Schloss, Rene ^b   Yarmush, Martin L ^b,c   Berthiaume, Francois ^b  

^a The State University of New Jersey   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Elastin like peptides (ELP); Nanoparticles; Skin; Stromal cell derived factor 1 (SDF1); Wound healing

Indexed keywords

BINS; BIOACTIVITY; DISSOCIATION; ELASTIN; ENZYME ACTIVITY; GLYCOPROTEINS; MAMMALS; NANOPARTICLES; PEPTIDES; RECOMBINANT PROTEINS; SKIN;

BINDING CHARACTERISTICS; BIOACTIVE PEPTIDES; EQUILIBRIUM DISSOCIATION CONSTANT; INTRACELLULAR CALCIUM; NEO-VASCULARIZATION; RE-EPITHELIALIZATION; STROMAL CELLS; WOUND HEALING;

PROTEINS;

CALCIUM; CHEMOKINE RECEPTOR CXCR4; HYBRID PROTEIN; NANOPARTICLE; STROMAL CELL DERIVED GROWTH FACTOR 1 ELASTIN LIKE PEPTIDE FUSION PROTEIN; UNCLASSIFIED DRUG; ELASTIN; PEPTIDE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CALCIUM TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; DISSOCIATION CONSTANT; DRUG RECEPTOR BINDING; HL 60 CELL LINE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INJURY; WOUND HEALING; ANIMAL; DRUG EFFECTS; HL-60 CELL LINE; HUMAN; INJURIES; METABOLISM; SKIN; TRANSGENIC MOUSE;

ANIMALS; CHEMOKINE CXCL12; DIABETES MELLITUS; ELASTIN; HL-60 CELLS; HUMANS; MICE, TRANSGENIC; NANOPARTICLES; PEPTIDES; RECEPTORS, CXCR4; RECOMBINANT FUSION PROTEINS; SKIN; WOUND HEALING;

EID: 84966270760     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.04.020     Document Type: Article

References (45)

1. C.K. Sen, G.M. Gordillo, S. Roy, R. Kirsner, L. Lambert, T.K. Hunt, F. Gottrup, G.C. Gurtner, and M.T. Longaker Human skin wounds: A major and snowballing threat to public health and the economy Wound Repair Regen. 17 2009 763 771
2. A. Tellechea, E. Leal, A. Veves, and E. Carvalho Inflammatory and angiogenic abnormalities in diabetic wound healing: role of neuropeptides and therapeutic perspectives TOCVJ 3 2010 43 55
3. R. Edwards, and K.G. Harding Bacteria and wound healing Curr. Opin. Infect. Dis. 17 2004 91 96
4. S.A. Eming, T. Krieg, and J.M. Davidson Inflammation in wound repair: molecular and cellular mechanisms J. Investig. Dermatol. 127 2007 514 525
5. H. Brem, and M. Tomic-Canic Cellular and molecular basis of wound healing in diabetes J. Clin. Invest. 117 2007 1219 1222
6. X. Xu, F. Zhu, M. Zhang, D. Zeng, D. Luo, G. Liu, W. Cui, S. Wang, W. Guo, W. Xing, H. Liang, L. Li, X. Fu, J. Jiang, and H. Huang Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization Cells Tissues Organs 197 2013 103 113
7. A.L. George, P. Bangalore-Prakash, S. Rajoria, R. Suriano, A. Shanmugam, A. Mittelman, and R.K. Tiwari Endothelial progenitor cell biology in disease and tissue regeneration J. Hematol. Oncol. 4 2011 24
8. C. Kalka, H. Masuda, T. Takahashi, W.M. Kalka-Moll, M. Silver, M. Kearney, T. Li, J.M. Isner, and T. Asahara Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization Proc. Natl. Acad. Sci. U. S. A. 97 2000 3422 3427
9. S.M. Majka, K.A. Jackson, K.A. Kienstra, M.W. Majesky, M.A. Goodell, and K.K. Hirschi Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration J. Clin. Invest. 111 2003 71 79
10. T. Takahashi, C. Kalka, H. Masuda, D. Chen, M. Silver, M. Kearney, M. Magner, J.M. Isner, and T. Asahara Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization Nat. Med. 5 1999 434 438
11. W.B. Bollag, and W.D. Hill CXCR4 in epidermal keratinocytes: crosstalk within the skin J. Investig. Dermatol. 133 2013 2505 2508
12. A. Sarkar, S. Tatlidede, S.S. Scherer, D.P. Orgill, and F. Berthiaume Combination of stromal cell-derived factor-1 and collagen-glycosaminoglycan scaffold delays contraction and accelerates reepithelialization of dermal wounds in wild-type mice Wound Repair Regen. 19 2011 71 79
13. M. Ziegler, M. Elvers, Y. Baumer, C. Leder, C. Ochmann, T. Schonberger, T. Jurgens, T. Geisler, B. Schlosshauer, O. Lunov, S. Engelhardt, T. Simmet, and M. Gawaz The bispecific SDF1-GPVI fusion protein preserves myocardial function after transient ischemia in mice Circulation 125 2012 685 696
14. V.F. Segers, T. Tokunou, L.J. Higgins, C. MacGillivray, J. Gannon, and R.T. Lee Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction Circulation 116 2007 1683 1692
15. O.O. Yang, S.L. Swanberg, Z. Lu, M. Dziejman, J. McCoy, A.D. Luster, B.D. Walker, and S.H. Herrmann Enhanced inhibition of human immunodeficiency virus type 1 by met-stromal-derived factor 1beta correlates with down-modulation of CXCR4 J. Virol. 73 1999 4582 4589
16. W. Hiesinger, J.M. Perez-Aguilar, P. Atluri, N.A. Marotta, J.R. Frederick, J.R. Fitzpatrick 3rd, R.C. McCormick, J.R. Muenzer, E.C. Yang, R.D. Levit, L.J. Yuan, J.W. Macarthur, J.G. Saven, and Y.J. Woo Computational protein design to reengineer stromal cell-derived factor-1alpha generates an effective and translatable angiogenic polypeptide analog Circulation 124 2011 S18 S26
17. W. Hiesinger, A.B. Goldstone, and Y.J. Woo Re-engineered stromal cell-derived factor-1alpha and the future of translatable angiogenic polypeptide design Trends Cardiovasc. Med. 22 2012 139 144
18. L. Baumann, S. Prokoph, C. Gabriel, U. Freudenberg, C. Werner, and A.G. Beck-Sickinger A novel, biased-like SDF-1 derivative acts synergistically with starPEG-based heparin hydrogels and improves eEPC migration in vitro J. Control. Release 162 2012 68 75
19. S.Y. Rabbany, J. Pastore, M. Yamamoto, T. Miller, S. Rafii, R. Aras, and M. Penn Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing Cell Transplant. 19 2010 399 408
20. P.W. Henderson, S.P. Singh, D.D. Krijgh, M. Yamamoto, D.C. Rafii, J.J. Sung, S. Rafii, S.Y. Rabbany, and J.A. Spector Stromal-derived factor-1 delivered via hydrogel drug-delivery vehicle accelerates wound healing in vivo Wound Repair Regen. 19 2011 420 425
21. F. Dalonneau, X.Q. Liu, R. Sadir, J. Almodovar, H.C. Mertani, F. Bruckert, C. Albiges-Rizo, M. Weidenhaupt, H. Lortat-Jacob, and C. Picart The effect of delivering the chemokine SDF-1alpha in a matrix-bound manner on myogenesis Biomaterials 35 2014 4525 4535
22. M.A. Olekson, R. Faulknor, A. Bandekar, M. Sempkowski, H.C. Hsia, and F. Berthiaume SDF-1 liposomes promote sustained cell proliferation in mouse diabetic wounds Wound Repair Regen. 2015
23. M.F. Shamji, H. Betre, V.B. Kraus, J. Chen, A. Chilkoti, R. Pichika, K. Masuda, and L.A. Setton Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic Arthritis Rheum. 56 2007 3650 3661
24. S.R. MacEwan, W. Hassouneh, and A. Chilkoti Non-chromatographic purification of recombinant elastin-like polypeptides and their fusions with peptides and proteins from Escherichia coli J. Vis. Exp. 2014
25. W. Hassouneh, T. Christensen, and A. Chilkoti Elastin-like polypeptides as a purification tag for recombinant proteins Curr. Protoc. Protein Sci. 2010 11 Unit 6. (Chapter 6)
26. D.E. Meyer, and A. Chilkoti Purification of recombinant proteins by fusion with thermally-responsive polypeptides Nat. Biotechnol. 17 1999 1112 1115
27. M. Amiram, K.M. Luginbuhl, X. Li, M.N. Feinglos, and A. Chilkoti A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection J. Control. Release 172 2013 144 151
28. P. Koria, H. Yagi, Y. Kitagawa, Z. Megeed, Y. Nahmias, R. Sheridan, and M.L. Yarmush Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds Proc. Natl. Acad. Sci. U. S. A. 108 2011 1034 1039
29. P. Loetscher, J.H. Gong, B. Dewald, M. Baggiolini, and I. Clark-Lewis N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities J. Biol. Chem. 273 1998 22279 22283
30. E.K. Ryu, T.G. Kim, T.H. Kwon, I.D. Jung, D. Ryu, Y.M. Park, J. Kim, K.H. Ahn, and C. Ban Crystal structure of recombinant human stromal cell-derived factor-1alpha Proteins 67 2007 1193 1197
31. J. Yang, R. Yan, A. Roy, D. Xu, J. Poisson, and Y. Zhang The I-TASSER suite: protein structure and function prediction Nat. Methods 12 2015 7 8
32. A. Roy, A. Kucukural, and Y. Zhang I-TASSER: A unified platform for automated protein structure and function prediction Nat. Protoc. 5 2010 725 738
33. Y. Zhang I-TASSER server for protein 3D structure prediction BMC Bioinf. 9 2008 40
34. R. Salcedo, K. Wasserman, H.A. Young, M.C. Grimm, O.M. Howard, M.R. Anver, H.K. Kleinman, W.J. Murphy, and J.J. Oppenheim Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha Am. J. Pathol. 154 1999 1125 1135
35. M.P. Crump, J.H. Gong, P. Loetscher, K. Rajarathnam, A. Amara, F. Arenzana-Seisdedos, J.L. Virelizier, M. Baggiolini, B.D. Sykes, and I. Clark-Lewis Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1 EMBO J. 16 1997 6996 7007
36. G.A. McQuibban, G.S. Butler, J.H. Gong, L. Bendall, C. Power, I. Clark-Lewis, and C.M. Overall Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1 J. Biol. Chem. 276 2001 43503 43508
37. A. Aiuti The chemokine SDF-1 is a chemoattractant for human CD34 + hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34 + progenitors to peripheral blood J. Exp. Med. 185 1997 111 120
38. A. Valenzuela-Fernández, T. Planchenault, F. Baleux, I. Staropoli, K. Le-Barillec, D. Leduc, T. Delaunay, F. Lazarini, J. Virelizier, M. Chignard, D. Pidard, and F. Arenzana-Seisdedos Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4 J. Biol. Chem. 277 2002 15677 15689
39. C. Bogani, V. Ponziani, P. Guglielmelli, C. Desterke, V. Rosti, A. Bosi, M.C. Le Bousse-Kerdiles, G. Barosi, and A.M. Vannucchi C. myeloproliferative disorders research, hypermethylation of CXCR4 promoter in CD34 + cells from patients with primary myelofibrosis Stem Cells 26 2008 1920-1930
40. W. Hiesinger, J.R. Frederick, P. Atluri, R.C. McCormick, N. Marotta, J.R. Muenzer, and Y.J. Woo Spliced stromal cell-derived factor-1alpha analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction J. Thorac. Cardiovasc. Surg. 140 2010 1174 1180
41. H.J. Kang, J.H. Kim, W.J. Chang, E.S. Kim, and Y.M. Koo Heterologous expression and optimized one-step separation of levansucrase via elastin-like polypeptides tagging system J. Microbiol. Biotechnol. 17 2007 1751 1757
42. F. Hu, T. Ke, X. Li, P.H. Mao, X. Jin, F.L. Hui, X.D. Ma, and L.X. Ma Expression and purification of an antimicrobial peptide by fusion with elastin-like polypeptides in Escherichia coli Appl. Biochem. Biotechnol. 160 2010 2377 2387
43. I. Hadad, A. Veithen, J.Y. Springael, P.A. Sotiropoulou, A. Mendes Da Costa, F. Miot, R. Naeije, X. De Deken, and K.M. Entee Stroma cell-derived factor-1alpha signaling enhances calcium transients and beating frequency in rat neonatal cardiomyocytes PLoS One 8 2013 e56007
44. L. Zhou, X. Guo, J. Ba, and L. Zhao CD44 is involved in CXCL-12 induced acute myeloid leukemia HL-60 cell polarity Biocell 34 2010 91 94
45. S. Prokoph, E. Chavakis, K.R. Levental, A. Zieris, U. Freudenberg, S. Dimmeler, and C. Werner Sustained delivery of SDF-1alpha from heparin-based hydrogels to attract circulating pro-angiogenic cells Biomaterials 33 2012 4792 4800